Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-07-21
1989-02-07
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549467, A61K 3134, C07D30781
Patent
active
048032190
ABSTRACT:
N,N-dimethyl-N'-benzoyl-N'-(2,3-dihydrobenzofuran-2-ylmethyl)1,3-propanedia mine of formula: ##STR1## and its pharmaceutically acceptable salts, in racemic form or in the form of enantiomers, which compounds have anti-arrhythmic properties.
REFERENCES:
patent: 4059621 (1977-11-01), Vincent et al.
Remington's Pharmaceutical Sciences, Gennaro et al., Editor, 17th Edition, p. 859 (1985).
Chemical Abstracts, vol. 69, No. 25, pp. 9955-9956, Item #106373P (1968).
Wagner et al., Synthetic Org. Chem.-Wiley, pp. 566 and 567 (1953). Fieser and Fieser, Advanced Org. Chem.-Reinhold, pp. 85-88 (1961).
Bernet Yvon
Combourieu Michel
Landes Marie-Paule
Simbille Nadine
Blackstone William M.
Dentz Bernard I.
Ford John M.
Riom Laboratories C.E.R.M.
LandOfFree
1,3-propanediamine derivatives and antiauhythnic pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-propanediamine derivatives and antiauhythnic pharmaceutical , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-propanediamine derivatives and antiauhythnic pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1085071